Campylobacter laridis has occasionally been isolated from patients with diarrhea, but its clinical significance in this setting has yet to be established. We report a patient with a self-limited diarrheal illness whose stool cultures yielded C. laridis. The patient also developed a specific serum bactericidal antibody response to this strain of C. laridis, suggesting that the organism was causally related to the enteric illness.
Campylobacter laridis, a recently described species (1), has been isolated from a variety of birds and animals (1, 11) , but human illness associated with this organism has been infrequently recognized. Moreover, even when C. laridis has been recovered from humans, its role as an enteric pathogen was not clearly established. We report a patient with C. laridis-associated enteritis who developed specific serum bactericidal antibodies to the strain isolated. This suggests a causal role for the organism in the illness of this patient.
CASE REPORT
In November 1985, a previously healthy 32-year-old male consulted his family physician because of diarrhea. Five days earlier he had had the onset of anorexia, nausea without vomiting, and crampy bilateral lower abdominal pain. The next day he developed diarrhea, with up to 10 mucoid, nonbloody bowel movements per day. He felt feverish but did not measure his temperature. By the time he saw his physician, symptomatic improvement had already begun. Stool cultures obtained on day 5 of his illness yielded C. laridis. No other enteric pathogens were recovered, and examination for ova and parasites was negative. The patient did not take any antimicrobial agents or other medications, and the duration of illness was 6 days. Follow-up stool cultures, 1 month after his recovery from the diarrheal illness, did not yield Campylobacter or any other enteric pathogens.
There was no history of recent travel out of the province and no known contact with anyone with an enteric illness. The patient's work as a hospital administrator did not involve direct patient contact. He had not consumed any unpasteurized milk or milk products or undercooked meat; he had eaten chicken at a hotel restaurant 2 days before the onset of illness. He had no pets, and there was no other animal or avian contact; in particular, there was no contact with seagulls.
MATERIALS AND METHODS
Feces were inoculated onto conventional enteric media for the recovery of Salmonella, Shigella, and Yersinia species. Stools were cultured for Campylobacter species by using a modified Skirrow medium (5) and a charcoal-based selective medium (6) , which were incubated at 42°C in a microaerophilic environment. Biochemical characterization of the patient's Campylobacter isolate was done by the methods of Benjamin et al. (1), except as follows. (i) Hippurate hydrolysis was done by the rapid method of Hwang and Ederer (3), and (ii) H2S production, DNA hydrolysis, and anaerobic growth in the presence of trimethylamine N-oxide dihydrate were done as described by Lior (8) . Antimicrobial susceptibility testing of the isolate was done at 35°C by a standard agar dilution technique (4).
Serum was obtained from the patient 2 weeks after the onset of diarrhea and at monthly intervals for 6 months for serological testing by a serum bactericidal assay as described by Karmali and Fleming (5) . The specificity of the serological response was determined by doing the test in parallel with sera from three healthy adults and by testing the patient's sera against his own Campylobacter isolate, a reference strain of C. laridis (NCTC 11352), and a recent clinical isolate of Campylobacterjejuni.
RESULTS
After 24 h of incubation, stool cultures yielded a heavy and pure growth of smooth, translucent, spreading colonies on both campylobacter media. A Gram stain revealed curved gram-negative bacilli with an appearance typical of Campylobacter spp. The organism was identified as C. laridis biovar I (Lior scheme) by accepted criteria (1, 7, 8) . This was confirmed by the National Reference Service for Campylobacters (Laboratory Centre for Disease Control, Ottawa, Ontario, Canada). Important characteristics of this isolate and, for comparison, those of reference strains of C. laridis (NCTC 11352), C. jejuni, and Campylobacter coli are shown in Table 1 . The organism was found to be resistant to trimethoprim, trimethoprim-sulfamethoxazole, vancomycin, penicillin G, cephalothin, cefoxitin, cefotaxime, and cefoperazone. It was susceptible to norfloxacin, amikacin, gentamicin, erythromycin, tetracycline, and ampicillin.
The patient's antibody titers, as measured by serum bactericidal assay, remained unchanged for 6 months after acute illness. The titers for his own isolate, for C. laridis NCTC 11352, and for the C. jejuni strain were 1:256, 1:32, and 1:8, respectively. The sera from the three healthy adults were antibody negative or had low titers of antibody (1:8 to 1:16) to all three organisms.
DISCUSSION
The organisms now known as C. laridis were first described as nalidixic acid-resistant thermophilic campylobacters by Skirrow and Benjamin (11) . The first human isolates were reported to be from the feces of four asymptomatic . Until now, no serological studies in patients with C. laridis-associated illness have been reported, and evidence for pathogenicity is lacking. Unfortunately, an acute-phase serological specimen from our patient was not available, so that seroconversion could not be documented. However, a convalescent-phase serum bactericidal antibody titer of 1:256 persisting for at least 6 months and specific to the strain isolated was found. The relatively high magnitude of this antibody response is comparable to that seen with convalescent-phase C. jejuni enteritis (5) . These results therefore provide further support for the etiological role of C. laridis in this patient's illness.
As in the present case, illness associated with C. laridis appears to be characterized primarily by diarrhea which is nonbloody, self-limiting, and often accompanied by crampy abdominal pain but little or no fever. The epidemiology of human illness associated with this organism remains uncertain. C. laridis appears to be widespread in nature. It was initially recovered from the cloacal contents of wild herring gulls, and a variety of birds and animals were subsequently found to be colonized with the organism (9, 11). However, unlike the C. jejuni-C. coli group of organisms, C. laridis does not appear to be a common isolate from domestic animals (9) . Neither the consumption of raw milk nor exposure to seagulls has been implicated in human cases of diarrhea associated with C. laridis.
The key feature differentiating C. laridis from other thermophilic campylobacters, particulary C. jejuni and C.
coli, is resistance to a 30-,ug disk of nalidixic acid. However, rare strains of C. jejuni resistant to nalidixic acid have been identified (1, 14) . Therefore, in the clinical laboratory, temperature tolerance, susceptibility to nalidixic acid, and hippurate hydrolysis should be done routinely to identify enteric Campylobacter isolates to the species level ( Table 1) . The production of H2S in iron metabisulfite medium may also be useful for distinguishing C. laridis from C. jejuni and C. coli (8, 12) . Anaerobic growth in the presence of trimethylamine N-oxide (0.1%) may be used as a confirmatory test for the identification of C. laridis (1) . In summary, the demonstration of a specific serological response in the present case provides further support for the pathogenic potential of C. laridis as a cause of enteric infection. However, it is clear that further clinical and epidemiological studies are required to better define the role of C. laridis in human disease.
